RILONACEPT REDUCES THE OCCURRENCE OF GOUT FLARES THAT MAY BE PRECIPITATED BY INITIATION OF URATE-LOWERING THERAPY

被引:0
|
作者
Knapp, H. R. [1 ]
Schumacher, R. [2 ]
Sundy, J. S. [3 ]
Terkeltauab, R. [4 ]
Mellis, S. [5 ]
King-Davis, S. [5 ]
Wu, R. [5 ]
Weinstein, S. [5 ]
Radin, A. [1 ,5 ]
机构
[1] Billings Clin Res Ctr, Billings, MT USA
[2] Univ Penn, VAMC, Philadelphia, PA 19104 USA
[3] Duke Univ, Durham, NC USA
[4] Univ Calif San Diego, La Jolla, CA 92093 USA
[5] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:164 / 164
页数:1
相关论文
共 50 条
  • [1] Serum urate and gout flares on urate-lowering therapy
    Thorley, Jennifer
    [J]. LANCET RHEUMATOLOGY, 2024, 6 (07): : E421 - E421
  • [2] Prophylaxis for acute gout flares after initiation of urate-lowering therapy
    Latourte, Augustin
    Bardin, Thomas
    Richette, Pascal
    [J]. RHEUMATOLOGY, 2014, 53 (11) : 1920 - 1926
  • [3] Prophylaxis on gout flares after the initiation of urate-lowering therapy: a retrospective research
    Feng, Xin
    Li, Yao
    Gao, Wei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11): : 21460 - 21465
  • [4] Case 8: Initiation of urate-lowering therapy for standard advanced gout
    Finley, J. Michael
    [J]. AMERICAN JOURNAL OF MEDICINE, 2006, 119 : 25 - 28
  • [5] Urate Lowering Therapy Initiation in Hospitalized Patients with Acute Gout Flares
    Fan, Emily
    Krause, Megan
    [J]. ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3582 - 3583
  • [6] EVALUATION OF RILONACEPT FOR PREVENTION OF GOUT FLARES DURING INITIATION OF URATE-LOWERING THERAPY: RESULTS OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRAIL
    Evans, Robert R.
    Terkeltaub, Robert
    Schumacher, H. Ralph
    Saag, Kenneth G.
    Clower, James
    Jennings, William
    Wang, Jian
    King-Davis, Shirletta
    Weinstsin, Steven P.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2011, 26 : S108 - S108
  • [7] Urate-lowering therapy for patients with gout on hemodialysis
    Alkilany, Reem
    Einstadter, Douglas
    Antonelli, Maria
    [J]. INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (07) : 769 - 774
  • [8] Adherence with urate-lowering therapy for the treatment of gout
    Harrold, Leslie R.
    Briesacher, Becky
    Raebel, Marsha
    Fouayzi, Hassan
    Yood, Robert
    Andrade, Susan
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S672 - S672
  • [9] Urate-Lowering Therapy for Gout: Focus on Febuxostat
    Love, Bryan L.
    Barrons, Robert
    Veverka, Angie
    Snider, K. Matthew
    [J]. PHARMACOTHERAPY, 2010, 30 (06): : 594 - 608
  • [10] Development of a patient decision aid for the initiation of urate-lowering therapy in gout patients
    te Kampe, Ritch
    Boonen, Annelies
    Jansen, Tim
    Janssen, Matthijs
    de Vries, Hein
    van Durme, Caroline
    [J]. RMD OPEN, 2022, 8 (01):